Clinical application of clustered-AChR for the detection of SNMG
Open Access
- 11 June 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 10193
Abstract
Myasthenia gravis (MG) is an autoantibody-mediated disease of the neuromuscular junction (NMJ). However, accumulating evidence has indicated that MG patients whose serum anti-acetylcholine receptor (AChR) antibodies are not detectable (serumnegative MG; SNMG) in routine assays share similar clinical features with anti-AChR antibody-positive MG patients. We hypothesized that SNMG patients would have low-affinity antibodies to AChRs that would not be detectable using traditional methods but that might be detected by binding to AChR on the cell membrane, particularly if they were clustered at the high density observed at the NMJ. We expressed AChR subunits with the clustering protein rapsyn (an AChR-associated protein at the synapse) in human embryonic kidney (HEK) cells and we tested the binding of the antibodies using immunofluorescence. With this approach, AChR antibodies to rapsyn-clustered AChR could be detected in the sera from 45.83% (11/24) of SNMG patients, as confirmed with fluorescence-activated cell sorting (FACS). This was the first application in China of cell-based AChR antibody detection. More importantly, this sensitive (and specific) approach could significantly increase the diagnosis rate of SNMG.Keywords
This publication has 20 references indexed in Scilit:
- Antibodies identified by cell‐based assays in myasthenia gravis and associated diseasesAnnals of the New York Academy of Sciences, 2012
- Formation et régénération synaptiqueNeurochirurgie, 2009
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- Overexpression of Rapsyn in Rat Muscle Increases Acetylcholine Receptor Levels in Chronic Experimental Autoimmune Myasthenia GravisThe American Journal of Pathology, 2007
- Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravisBrain, 2005
- Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among ChineseNeurology, 2004
- Induction, assembly, maturation and maintenance of a postsynaptic apparatusNature Reviews Neuroscience, 2001
- Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodiesNature Medicine, 2001
- Control of acetylcholine receptors in skeletal musclePhysiological Reviews, 1979
- Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.1971